Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Great Lakes Advisors LLC

Great Lakes Advisors LLC cut its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 5.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 129,496 shares of the health services provider's stock after selling 7,863 shares during the quarter. Great Lakes Advisors LLC owned 0.40% of Amedisys worth $11,888,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Treasurer of the State of North Carolina grew its position in shares of Amedisys by 1.0% in the 4th quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider's stock valued at $1,350,000 after buying an additional 140 shares during the last quarter. Arizona State Retirement System grew its position in shares of Amedisys by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider's stock valued at $840,000 after buying an additional 177 shares during the last quarter. Louisiana State Employees Retirement System grew its position in shares of Amedisys by 2.2% in the 1st quarter. Louisiana State Employees Retirement System now owns 9,400 shares of the health services provider's stock valued at $866,000 after buying an additional 200 shares during the last quarter. Bridge City Capital LLC boosted its stake in Amedisys by 0.8% during the 1st quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider's stock worth $2,752,000 after purchasing an additional 231 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in Amedisys by 0.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider's stock worth $2,876,000 after purchasing an additional 255 shares during the period. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Trading Up 0.0 %

AMED stock traded up $0.02 during midday trading on Friday, reaching $97.17. 495,025 shares of the company's stock traded hands, compared to its average volume of 328,482. The company has a market capitalization of $3.18 billion, a P/E ratio of -151.83, a PEG ratio of 1.92 and a beta of 0.78. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $98.95. The business has a 50-day moving average price of $97.75 and a two-hundred day moving average price of $94.59.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.10. The firm had revenue of $591.19 million for the quarter, compared to analysts' expectations of $579.34 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. Equities research analysts forecast that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AMED. William Blair cut shares of Amedisys from an "outperform" rating to a "market perform" rating in a research note on Monday, July 1st. Cantor Fitzgerald restated a "neutral" rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Amedisys from a "buy" rating to a "hold" rating and set a $101.00 target price for the company. in a research note on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $100.67.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.